Vimarsana
Biggest News Aggregation in the World

Page 27 - Vitro Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vitro Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vitro Diagnostics Today - Breaking & Trending Today

Mursla Bio Unlocks New Biomarker Discovery Approach in Liquid Biopsy and Precision Medicine - Vimarsana News

Mursla Bio Unlocks New Biomarker Discovery Approach in Liquid Biopsy and Precision Medicine

Mursla Bio to showcase its novel tissue-specific extracellular vesicle isolation technology at ISEV2023 Mursla Bio will present its novel tissue-specific Extracellular Vesicle (EV) isolation technology

Mursla Bio unlocks new biomarker discovery approach in liquid biopsy and precision medicine - Vimarsana News

Mursla Bio unlocks new biomarker discovery approach in liquid biopsy and precision medicine

Mursla Bio will present its novel tissue-specific Extracellular Vesicle (EV) isolation technology NEXPLOR at the International Society for Extracellular Vesicles (ISEV) annual meeting.

In Vitro Diagnostics for Early Cancer Detection: The Evolution and Promise of Liquid Biopsy Technology, Upcoming Webinar Hosted by Xtalks - Vimarsana News

In Vitro Diagnostics for Early Cancer Detection: The Evolution and Promise of Liquid Biopsy Technology, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) May 10, 2023 -- As liquid biopsies become more commonplace, gaining wider US Food and Drug Administration (FDA) acceptance and even

Source: prweb.com
Xtalks Announces its Life Science Webinar Calendar for May 2023 - Vimarsana News

Xtalks Announces its Life Science Webinar Calendar for May 2023

Toronto, ON (PRWEB) May 05, 2023 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical

Source: prweb.com
CardioGenics (OTCMKTS:CGNH) Stock Crosses Above 200 Day Moving Average of $0.00 - Vimarsana News

CardioGenics (OTCMKTS:CGNH) Stock Crosses Above 200 Day Moving Average of $0.00

CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Rating)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares changing hands. CardioGenics Price Performance CardioGenics Company Profile […]